Skip to main content


You are here Baltimore: SilcsBio’s Drug Design Algorithms Get Patent

Monday, July 16, 2018

The technology was invented at the University of Maryland, Baltimore

Algorithms used in a Spark Baltimore–based company’s software was recently patented for algorithms that will help it expand its presence in the market, according to its CEO.

SilcsBio is bringing software to the pharmaceutical process of finding new medications. The company makes software that’s designed to help pharmaceutical companies with parts of the process of developing new treatments, including a method to seek out compounds that could potentially be developed. The company licensed technology from the University of Maryland, Baltimore.

According to CEO Ken Malone, the startup’s patent covers algorithms invented by Alex MacKerell of UMB andOlgun Guvench of the University of New England, College of Pharmacy.

Click here to read the rest of the story via Baltimore.